Authors Beaulieu P, Boulanger A, Desroches J, Clark AJ Abstract PURPOSE: New regulations are in place at the federal and provincial levels in Canada regarding the way medicalcannabis is to be controlled. We present them together with guidance for the safe Read More …
Category: Research
CBD-enriched medical cannabis for intractable pediatric epil …
Authors Tzadok M, Uliel-Siboni S, Linder I, Kramer U, Epstein O, Menascu S, Nissenkorn A, Yosef OB, Hyman E, Granot D, Dor M, Lerman-Sagie T, Ben-Zeev B Highlights •CBD-enriched medical cannabis is a promising treatment for intractable epilepsy. •Only minor and infrequent Read More …
Taming THC: potential cannabis synergy and phytocannabinoid- …
Author: Ethan B Russo Abstract Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia have been scientifically demonstrated. Other Read More …
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neurophysiological Assessment in Multiple Sclerosis.
#VALUE!
Evaluating Sativex® in Neuropathic Pain Management: A Clini …
Authors: Russo M, Naro A, Leo A, Sessa E, D’Aleo G, Bramanti P, Calabrò RS. Abstract OBJECTIVE : The aim of our study was to better investigate the role of Sativex® in improving pain in multiple sclerosis (MS) patients by means of Read More …
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson’s disease
Authors: C García, C Palomo-Garo1, M García-Arencibia, JA Ramos, RG Pertwee, and J Fernández-Ruiz. BACKGROUND AND PURPOSE Previous findings have indicated that a cannabinoid, such as Δ9-THCV, which has antioxidant properties and the ability to activate CB2 receptors but to block CB1, might be a promising therapy Read More …
Symptom-relieving and neuroprotective effects of the phytoca …
BACKGROUND AND PURPOSE Previous findings have indicated that a cannabinoid, such as Δ9-THCV, which has antioxidant properties and the ability to activate CB2 receptors but to block CB1, might be a promising therapy for alleviating symptoms and delaying neurodegeneration in Read More …
Taming THC: potential cannabis synergy and phytocannabinoid- …
Author Russo EB Abstract Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia have been scientifically demonstrated. Other phytocannabinoids, Read More …
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Author Russo EB Abstract Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia have been scientifically demonstrated. Other phytocannabinoids, Read More …
Peripherally Restricted Cannabinoids for the Treatment of Pa …
Authors: Romero-Sandoval EA, Asbill S, Paige CA, Byrd-Glover K. Abstract The use of cannabinoids for the treatment of chronic diseases has increased in the United States, with 23 states having legalized the use of marijuana. Although currently available cannabinoid compounds have Read More …